BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26911285)

  • 1. "Siglec"ting the allergic response for therapeutic targeting.
    Bochner BS
    Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, Function, and Therapeutic Targeting of Siglec-8.
    Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
    O'Sullivan JA; Carroll DJ; Cao Y; Salicru AN; Bochner BS
    J Allergy Clin Immunol; 2018 May; 141(5):1774-1785.e7. PubMed ID: 28734845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
    Farid SSh; Mirshafiey A; Razavi A
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.
    Wei Y; Chhiba KD; Zhang F; Ye X; Wang L; Zhang L; Robida PA; Moreno-Vinasco L; Schnaar RL; Roers A; Hartmann K; Lee CM; Demers D; Zheng T; Bochner BS; Zhu Z
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression.
    Hudson SA; Herrmann H; Du J; Cox P; Haddad el-B; Butler B; Crocker PR; Ackerman SJ; Valent P; Bochner BS
    J Clin Immunol; 2011 Dec; 31(6):1045-53. PubMed ID: 21938510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bryce PJ; Bright J; Williams J; Shultz LD; Greiner DL; Brehm MA; Bebbington C; Tomasevic N
    Int Arch Allergy Immunol; 2019; 180(2):91-102. PubMed ID: 31401630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
    Tateno H; Crocker PR; Paulson JC
    Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
    Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
    Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
    Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
    Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
    Bochner BS
    Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils.
    Kikly KK; Bochner BS; Freeman SD; Tan KB; Gallagher KT; D'alessio KJ; Holmes SD; Abrahamson JA; Erickson-Miller CL; Murdock PR; Tachimoto H; Schleimer RP; White JR
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1093-100. PubMed ID: 10856141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression.
    Schleimer RP; Schnaar RL; Bochner BS
    Curr Opin Allergy Clin Immunol; 2016 Feb; 16(1):24-30. PubMed ID: 26694037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
    Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
    Front Immunol; 2021; 12():650331. PubMed ID: 33777047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
    Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
    J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bochner BS; Rasmussen HS; Peterson K; Bebbington C; Tomasevic N
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.
    Zhang M; Angata T; Cho JY; Miller M; Broide DH; Varki A
    Blood; 2007 May; 109(10):4280-7. PubMed ID: 17272508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge.
    Johansson MW; Kelly EA; Nguyen CL; Jarjour NN; Bochner BS
    Int Arch Allergy Immunol; 2018; 177(1):16-28. PubMed ID: 29879704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
    Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
    J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.